NasdaqGS:REGNBiotechs
Regeneron Pharmaceuticals First Quarter 2025 Earnings: Revenues Disappoint
Regeneron Pharmaceuticals ( NASDAQ:REGN ) First Quarter 2025 Results Key Financial Results Revenue: US$3.03b (down 3.7...
Stock Analysis
Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.